• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈部淋巴结原发不明癌的临床病理特征

Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes.

作者信息

Weiss Daniel, Koopmann Mario, Stenner Markus, Savvas Eleftherios, Rudack Claudia

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University of Münster, Kardinal-von-Galen-Ring 10, 48149, Münster, Germany,

出版信息

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):431-7. doi: 10.1007/s00405-014-2980-z. Epub 2014 Mar 17.

DOI:10.1007/s00405-014-2980-z
PMID:24633307
Abstract

Carcinoma in cervical lymph nodes of unknown origin represents a rare clinical entity where optimal diagnostic and therapeutic management is still a widely debated issue. Molecular classification of these metastases is thus of utmost importance. We analyzed the expression of eight basic molecular markers in 26 metastases from unknown primaries, 31 metastases from overt primaries and their associated primaries. Medical records of the respective patients were reviewed for main clinicopathological parameters. The expression rates showed no significant differences between the two tumor entities, neither in absolute terms nor in comparison among the parameters. Surprisingly, patients with metastases from unknown primary demonstrated improved progression-free survival (p = 0.046) despite advanced age (p = 0.029), advanced nodal stage (p = 0.006) and higher incidence of extracapsular spread (p = 0.045) compared to patients with metastases from overt primaries. Presence of extracapsular spread was associated with increased expression of epidermal growth factor receptor in metastases from overt primaries (p = 0.035) and reduced expression of matrix metalloproteinase-2 in metastases from unknown primary (p = 0.031). We thus conclude that cervical metastases from unknown and overt primaries show similarities in their molecular profile, but fundamental differences in clinical parameter.

摘要

原发灶不明的颈部淋巴结癌是一种罕见的临床实体,其最佳诊断和治疗管理仍是一个广泛争论的问题。因此,对这些转移灶进行分子分类至关重要。我们分析了26例原发灶不明转移灶、31例明确原发灶转移灶及其相关原发灶中8种基本分子标志物的表达情况。回顾了各患者的病历以获取主要临床病理参数。表达率在这两种肿瘤实体之间没有显著差异,无论是绝对值还是参数之间的比较。令人惊讶的是,与明确原发灶转移灶的患者相比,原发灶不明转移灶的患者尽管年龄较大(p = 0.029)、淋巴结分期较晚(p = 0.006)和包膜外扩散发生率较高(p = 0.045),但无进展生存期有所改善(p = 0.046)。包膜外扩散的存在与明确原发灶转移灶中表皮生长因子受体表达增加(p = 0.035)以及原发灶不明转移灶中基质金属蛋白酶-2表达降低(p = 0.031)相关。因此,我们得出结论,原发灶不明和明确原发灶的颈部转移灶在分子特征上显示出相似性,但在临床参数上存在根本差异。

相似文献

1
Clinicopathological characteristics of carcinoma from unknown primary in cervical lymph nodes.颈部淋巴结原发不明癌的临床病理特征
Eur Arch Otorhinolaryngol. 2015 Feb;272(2):431-7. doi: 10.1007/s00405-014-2980-z. Epub 2014 Mar 17.
2
The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary.原发灶不明的颈部淋巴结转移性鳞状细胞癌的管理
Am J Clin Oncol. 1998 Apr;21(2):121-5. doi: 10.1097/00000421-199804000-00004.
3
Cervical nodal metastasis of squamous cell carcinoma of unknown origin: indications for withholding radiation therapy.原发灶不明的鳞状细胞癌颈部淋巴结转移:暂不进行放射治疗的指征
Int J Radiat Oncol Biol Phys. 1992;23(4):743-9. doi: 10.1016/0360-3016(92)90647-z.
4
Cervical metastases from unknown primaries: radiotherapeutic management and appearance of subsequent primaries.
Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):919-28. doi: 10.1016/0360-3016(90)90013-a.
5
Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes.颈部转移的未知原发癌分析:诊断、治疗及预后
J Ky Med Assoc. 2006 Feb;104(2):57-64.
6
Phospho-Rb (Ser780) as a biomarker in patients with cervical lymph node metastases from an unknown primary tumour: a retrospective cohort study.磷酸化 Rb(Ser780)作为不明原发肿瘤颈淋巴结转移患者的生物标志物:一项回顾性队列研究。
Clin Otolaryngol. 2013 Aug;38(4):313-21. doi: 10.1111/coa.12138.
7
Squamous carcinoma presenting as an enlarged cervical lymph node.表现为颈部淋巴结肿大的鳞状细胞癌。
Cancer. 1993 Sep 1;72(5):1756-61. doi: 10.1002/1097-0142(19930901)72:5<1756::aid-cncr2820720540>3.0.co;2-5.
8
Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.免疫抑制患者皮肤鳞状细胞癌区域淋巴结转移率
Am J Otolaryngol. 2017 May-Jun;38(3):325-328. doi: 10.1016/j.amjoto.2017.01.035. Epub 2017 Feb 4.
9
Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.隐匿性原发肿瘤转移至颈部淋巴结的癌:综合治疗后的结局
Ann Surg Oncol. 2007 May;14(5):1575-82. doi: 10.1245/s10434-006-9329-9. Epub 2007 Feb 16.
10
Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.原发部位不明的颈部淋巴结鳞状细胞癌:颈淋巴结清扫术的影响
J Cancer Res Ther. 2015 Oct;11 Suppl 2:C161-7. doi: 10.4103/0973-1482.168178.

引用本文的文献

1
Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck.中性粒细胞与淋巴细胞比值在头颈部原发性不明的p16阴性鳞状细胞癌中的意义
Front Oncol. 2020 Jan 29;10:39. doi: 10.3389/fonc.2020.00039. eCollection 2020.

本文引用的文献

1
Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma.候选生物标志物 TCF21 在头颈部鳞状细胞癌中的蛋白表达和启动子甲基化。
Cell Oncol (Dordr). 2013 Jun;36(3):213-24. doi: 10.1007/s13402-013-0129-5. Epub 2013 Mar 26.
2
Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer.基于证据的头颈部癌症正电子发射断层成像应用指南建议。
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):e33-66. doi: 10.1016/j.clon.2012.08.007. Epub 2012 Sep 26.
3
Expression of matrix metalloproteinase-12 is correlated with extracapsular spread of tumor from nodes with metastasis in head and neck squamous cell carcinoma.
基质金属蛋白酶-12 的表达与头颈部鳞状细胞癌转移淋巴结中肿瘤的囊外扩散相关。
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1137-42. doi: 10.1007/s00405-012-2161-x. Epub 2012 Aug 21.
4
Radiotherapeutic management of cervical lymph node metastases from an unknown primary site.原发部位不明的颈部淋巴结转移瘤的放射治疗管理
Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):656-61. doi: 10.1001/archoto.2012.1110.
5
Cancer of unknown primary: does treatment modality make a difference?原发灶不明癌:治疗方式是否有差异?
Laryngoscope. 2012 Jun;122(6):1279-82. doi: 10.1002/lary.22424. Epub 2012 Apr 26.
6
Detection of the primary lesion in patients with cervical metastases from unknown primary tumors with narrow band imaging endoscopy: preliminary report.窄带成像内镜检测不明原发灶颈转移癌患者的原发病灶:初步报告。
Head Neck. 2013 Jan;35(1):10-4. doi: 10.1002/hed.22901. Epub 2012 Apr 8.
7
Cancer of unknown primary site.原发灶不明的癌症。
Lancet. 2012 Apr 14;379(9824):1428-35. doi: 10.1016/S0140-6736(11)61178-1. Epub 2012 Mar 12.
8
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在隐匿性头颈部癌症评估中的应用——已发表研究的审核和回顾。
Clin Oncol (R Coll Radiol). 2012 Apr;24(3):190-5. doi: 10.1016/j.clon.2011.11.001. Epub 2011 Dec 17.
9
Utility of panendoscopy for the detection of unknown primary head and neck cancer in patients with a negative PET/CT scan.全内镜检查在PET/CT扫描阴性的患者中检测未知原发头颈癌的效用。
Ear Nose Throat J. 2011 Aug;90(8):E16-20. doi: 10.1177/014556131109000818.
10
Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: a prospective clinical trial.PET/CT 在头颈部鳞癌原发灶不明评估中的临床应用:一项前瞻性临床试验。
Head Neck. 2011 Jul;33(7):935-40. doi: 10.1002/hed.21566. Epub 2010 Nov 12.